Health Knowledge Center

This article introduces Hodgkin lymphoma: common in teens, presents with lymphadenopathy. Chemo/radiotherapy effective, >90% early-stage, >85% high-risk 5-year survival.

This article introduces Burkitt lymphoma: aggressive pediatric B-cell NHL. Rapid onset, multi-site involvement. Risk-stratified chemo yields >80% 5-year survival overall.

This article introduces Lymphoblastic lymphoma: T/B-cell origin, common pediatric NHL. Chemotherapy main treatment, 75-90% 5-year survival. Similar to ALL but <25% marrow involvement.